Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q2)Sep 30, 2025 | (Q1)Jun 30, 2025 | (FY)Mar 31, 2025 | (Q4)Mar 31, 2025 | (Q3)Dec 31, 2024 | (Q2)Sep 30, 2024 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 48.62%-15.47K | -31.07%-11.5K | 22.82%-83.82K | 12.15%-37.47K | 46.66%-7.46K | 9.74%-30.11K | 52.81%-8.77K | 31.96%-108.59K | 0.97%-42.65K | 46.04%-13.99K |
| Net income from continuing operations | -6.44%-22.61K | 14.78%-19.9K | 22.06%-87.89K | -50.67%-36.2K | 80.10%-7.09K | 18.25%-21.24K | 13.88%-23.36K | 39.36%-112.77K | 57.02%-24.02K | -14.31%-35.64K |
| Deferred tax | ---- | ---- | --0 | ---- | ---- | ---- | ---- | -200.00%-14K | ---- | ---- |
| Change In working capital | 180.53%7.14K | -42.37%8.4K | -77.60%4.07K | 72.46%-1.28K | -101.71%-370 | -20.23%-8.87K | 71.01%14.58K | 46.87%18.17K | -292.04%-4.63K | 312.16%21.65K |
| -Change in receivables | -4,533.33%-399 | 4,960.00%1.01K | -143.28%-737 | -265.05%-1.4K | 140.30%632 | -97.41%9 | -91.87%20 | 41.33%1.7K | 201.32%847 | -99.23%263 |
| -Change in prepaid assets | --0 | --0 | 200.00%6.19K | 117.87%933 | -4.43%1.55K | 22.95%2K | 140.45%1.71K | -108.98%-6.19K | -757.56%-5.22K | 22.44%1.63K |
| -Change in payables and accrued expense | 215.32%12.54K | -42.49%7.39K | -106.11%-1.39K | -216.41%-810 | -112.93%-2.56K | -16.34%-10.87K | 2.80%12.85K | 139.24%22.66K | 77.52%-256 | 165.44%19.76K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 48.62%-15.47K | -31.07%-11.5K | 22.82%-83.82K | 12.15%-37.47K | 46.66%-7.46K | 9.74%-30.11K | 52.81%-8.77K | 31.96%-108.59K | 0.97%-42.65K | 46.04%-13.99K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 0 | -121.76%-1.23K | 483.89%14.2K | -67.24%18.7K | 70.26%-1.57K | 95.10%-2.37K | 92.17%-556 | 99.56%-3.7K | 1,172.04%57.09K | 48.13%-5.28K |
| Net PPE purchase and sale | --0 | -121.76%-1.23K | 92.78%-4.5K | --0 | 70.26%-1.57K | 95.10%-2.37K | 92.17%-556 | 92.54%-62.33K | 70.99%-1.55K | 48.13%-5.28K |
| Net other investing changes | ---- | ---- | -68.11%18.7K | ---- | ---- | ---- | ---- | --58.63K | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | --0 | -121.76%-1.23K | 483.89%14.2K | -67.24%18.7K | 70.26%-1.57K | 95.10%-2.37K | 92.17%-556 | 99.56%-3.7K | 1,172.04%57.09K | 48.13%-5.28K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | ||||||||||
| Cash from discontinued financing activities | ||||||||||
| Net cash flow | ||||||||||
| Beginning cash position | -79.17%19.21K | -68.55%31.94K | -52.51%101.56K | -41.79%50.72K | -43.84%59.75K | -50.98%92.23K | -52.51%101.56K | -82.31%213.85K | -66.78%87.13K | -64.34%106.4K |
| Current changes in cash | 529.61%139.53K | -36.47%-12.73K | 38.00%-69.62K | -230.09%-18.77K | 53.12%-9.03K | 60.27%-32.48K | 63.69%-9.33K | 88.72%-112.29K | 129.82%14.43K | 46.63%-19.27K |
| End cash Position | 165.67%158.74K | -79.17%19.21K | -68.55%31.94K | -68.55%31.94K | -41.79%50.72K | -43.84%59.75K | -50.98%92.23K | -52.51%101.56K | -52.51%101.56K | -66.78%87.13K |
| Free cash from | 52.38%-15.47K | -36.47%-12.73K | 48.33%-88.32K | 15.22%-37.47K | 53.12%-9.03K | 60.27%-32.48K | 63.69%-9.33K | 82.83%-170.92K | 8.68%-44.2K | 46.63%-19.27K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.